Schattenberg JM - Search Results

1

NAFLD and NASH: The Metabolically Diseased Liver.

Armandi A, Schattenberg JM. Armandi A, et al. Among authors: schattenberg jm. Handb Exp Pharmacol. 2022;274:253-267. doi: 10.1007/164_2021_561. Handb Exp Pharmacol. 2022. PMID: 34811578

2

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, Oliveira CP, Francque S, Van Gaal L, Schattenberg JM, Tiniakos D, Burt A, Bugianesi E, Ratziu V, Day CP, Anstee QM. McPherson S, et al. Among authors: schattenberg jm. Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11. Am J Gastroenterol. 2017. PMID: 27725647 Free PMC article.

3

Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.

Labenz C, Schattenberg JM. Labenz C, et al. Among authors: schattenberg jm. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040. Aliment Pharmacol Ther. 2018. PMID: 30488630 No abstract available.

4

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation.

Huber Y, Boyle M, Hallsworth K, Tiniakos D, Straub BK, Labenz C, Ruckes C, Galle PR, Romero-Gómez M, Anstee QM, Schattenberg JM; EPoS Consortium Investigators. Huber Y, et al. Among authors: schattenberg jm. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2085-2092.e1. doi: 10.1016/j.cgh.2018.12.016. Epub 2018 Dec 20. Clin Gastroenterol Hepatol. 2019. PMID: 30580090

5

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.

Gehrke N, Biedenbach J, Huber Y, Straub BK, Galle PR, Simon P, Schattenberg JM. Gehrke N, et al. Among authors: schattenberg jm. Sci Rep. 2019 Mar 8;9(1):4007. doi: 10.1038/s41598-018-38321-9. Sci Rep. 2019. PMID: 30850619 Free PMC article.

6

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD).

Schattenberg JM, Bergheim I. Schattenberg JM, et al. Nutrients. 2019 Mar 11;11(3):588. doi: 10.3390/nu11030588. Nutrients. 2019. PMID: 30862016 Free PMC article.

7

Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASH.

Schattenberg JM. Schattenberg JM. Liver Int. 2019 May;39(5):812-814. doi: 10.1111/liv.13999. Liver Int. 2019. PMID: 31020772 No abstract available.

8

Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers.

Schattenberg JM, Ekstedt M. Schattenberg JM, et al. BMC Med. 2019 Jul 4;17(1):123. doi: 10.1186/s12916-019-1357-y. BMC Med. 2019. PMID: 31269936 Free PMC article. No abstract available.

9

Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease.

Ashfaq-Khan M, Aslam M, Qureshi MA, Senkowski MS, Yen-Weng S, Strand S, Kim YO, Pickert G, Schattenberg JM, Schuppan D. Ashfaq-Khan M, et al. Among authors: schattenberg jm. Sci Rep. 2019 Nov 25;9(1):17463. doi: 10.1038/s41598-019-53323-x. Sci Rep. 2019. PMID: 31767938 Free PMC article.

10

Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.

Labenz C, Huber Y, Michel M, Nagel M, Galle PR, Kostev K, Schattenberg JM. Labenz C, et al. Among authors: schattenberg jm. Dig Dis Sci. 2020 Jul;65(7):2112-2119. doi: 10.1007/s10620-019-05986-9. Epub 2019 Dec 3. Dig Dis Sci. 2020. PMID: 31797186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters